Received Apr 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 1 | Z005021 | IM / LL |
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Z005021 | — |
no additional AE; administration of improperly stored vaccine; This spontaneous report was received from medical assistant and refers to a 1-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 15-APR-2026, the patient was vaccinated with improperly stored dose of Hepatitis A Vaccine, Inactivated Suspension for injection (VAQTA) (lot #Z005021 was valid for formulation pre-filled syringe, expiration date: 22-OCT-2026, exact dose, route of administration and anatomical location were not provided) for prophylaxis (Product storage error). No symptoms were reported. No additional adverse event (AE) (No adverse event). Temperature excursion of 14.9 degree Celsius (C) for 298 hours was reported. This is one of few reports from the same reporter.